2026 Global: 24-Hour Ambulatory Blood Pressure Monitor Market -Competitive Review (2032) report
Description
The 2026 Global: 24-Hour Ambulatory Blood Pressure Monitor Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for 24-hour ambulatory blood pressure monitor market by geography and historical trend. The scope of the report extends to sizing of the 24-hour ambulatory blood pressure monitor market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Ten major companies dominate the 24-hour ambulatory blood pressure monitor (ABPM) market: Spacelabs Healthcare, Welch Allyn (Hill‑Rom/Morton‑Welch), A&D Company, Microlife, Omron Healthcare, SunTech Medical (Mortara/GE lineage), Philips, B. Braun, Contec Medical, and Biobeat. Spacelabs Healthcare is widely recognized for clinical-grade ABPM systems used in hospitals and sleep labs and maintains a strong presence in ambulatory diagnostics with devices designed for long‑term, ambulatory recording of blood pressure and ECG; its products are commonly cited in clinical guidelines and research for 24‑hour monitoring reliability. Welch Allyn, now part of Hill‑Rom and with historical ties to Mortara and SunTech product lines, supplies robust NIBP and ABPM solutions favored by clinics for integration with vital‑sign workflows and durable cuff systems suitable for continuous outpatient use. A&D Company is known for validated, clinically accurate ABPM and home BP devices that emphasize regulatory compliance and repeatability of measurements across 24‑hour cycles, earning consistent mention in comparative device listings and clinical validation registries. Microlife produces both home and ambulatory monitors with automated algorithms for arrhythmia detection and ambulatory protocols; its devices are frequently validated and used in population screening and research settings. Omron Healthcare leads the consumer and professional markets with a broad portfolio spanning validated home monitors to professional ambulatory solutions that incorporate connectivity and data management for long‑term trend analysis and clinical review. SunTech Medical, historically aligned with Mortara and GE product families, offers ambulatory blood pressure systems engineered specifically for cuff‑based 24‑hour recording with emphasis on motion tolerance and cuff comfort during extended wear. Philips provides integrated patient monitoring platforms that can interface with ambulatory BP devices and hospital information systems, supporting remote data review and clinician workflows for extended BP monitoring use cases. B. Braun supplies medical devices including ABPM systems and accessories targeted at hospital and outpatient physician use, leveraging a broad device portfolio and clinical services for device deployment. Contec Medical and Contec’s related brands offer cost‑competitive ambulatory and long‑term BP monitors that are prevalent in emerging markets and primary care settings where affordability and basic 24‑hour functionality are prioritized. Biobeat represents a newer entrant focusing on wearable, wireless vital‑sign monitors including continuous BP estimation technologies and cloud connectivity aimed at remote patient monitoring and post‑discharge surveillance.
These ten firms differ by primary customers, product features, and geographic strength: Spacelabs, Welch Allyn, SunTech/Mortara, Philips, and B. Braun are strong in hospital and specialty clinic deployments where validated, research‑grade 24‑hour recordings and integration with clinical systems matter most. Omron, A&D, and Microlife bridge home and ambulatory segments by offering validated cuff‑based ABPMs plus connectivity and companion software that support clinician review of 24‑hour profiles and home‑to‑clinic data sharing. Contec and other low‑cost manufacturers serve high‑volume primary care and emerging markets with basic ABPM capability and competitive pricing. Biobeat and other digital health challengers emphasize continuous, cuffless estimation, cloud analytics, and remote monitoring workflows that target outpatient, telehealth, and post‑acute care use cases. Each company’s competitive advantage is shaped by clinical validation status, regulatory approvals, device comfort for overnight wear, data management and connectivity, and distribution channels that determine adoption in ambulatory hypertension diagnosis and management.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for 24-hour ambulatory blood pressure monitor market by geography and historical trend. The scope of the report extends to sizing of the 24-hour ambulatory blood pressure monitor market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Ten major companies dominate the 24-hour ambulatory blood pressure monitor (ABPM) market: Spacelabs Healthcare, Welch Allyn (Hill‑Rom/Morton‑Welch), A&D Company, Microlife, Omron Healthcare, SunTech Medical (Mortara/GE lineage), Philips, B. Braun, Contec Medical, and Biobeat. Spacelabs Healthcare is widely recognized for clinical-grade ABPM systems used in hospitals and sleep labs and maintains a strong presence in ambulatory diagnostics with devices designed for long‑term, ambulatory recording of blood pressure and ECG; its products are commonly cited in clinical guidelines and research for 24‑hour monitoring reliability. Welch Allyn, now part of Hill‑Rom and with historical ties to Mortara and SunTech product lines, supplies robust NIBP and ABPM solutions favored by clinics for integration with vital‑sign workflows and durable cuff systems suitable for continuous outpatient use. A&D Company is known for validated, clinically accurate ABPM and home BP devices that emphasize regulatory compliance and repeatability of measurements across 24‑hour cycles, earning consistent mention in comparative device listings and clinical validation registries. Microlife produces both home and ambulatory monitors with automated algorithms for arrhythmia detection and ambulatory protocols; its devices are frequently validated and used in population screening and research settings. Omron Healthcare leads the consumer and professional markets with a broad portfolio spanning validated home monitors to professional ambulatory solutions that incorporate connectivity and data management for long‑term trend analysis and clinical review. SunTech Medical, historically aligned with Mortara and GE product families, offers ambulatory blood pressure systems engineered specifically for cuff‑based 24‑hour recording with emphasis on motion tolerance and cuff comfort during extended wear. Philips provides integrated patient monitoring platforms that can interface with ambulatory BP devices and hospital information systems, supporting remote data review and clinician workflows for extended BP monitoring use cases. B. Braun supplies medical devices including ABPM systems and accessories targeted at hospital and outpatient physician use, leveraging a broad device portfolio and clinical services for device deployment. Contec Medical and Contec’s related brands offer cost‑competitive ambulatory and long‑term BP monitors that are prevalent in emerging markets and primary care settings where affordability and basic 24‑hour functionality are prioritized. Biobeat represents a newer entrant focusing on wearable, wireless vital‑sign monitors including continuous BP estimation technologies and cloud connectivity aimed at remote patient monitoring and post‑discharge surveillance.
These ten firms differ by primary customers, product features, and geographic strength: Spacelabs, Welch Allyn, SunTech/Mortara, Philips, and B. Braun are strong in hospital and specialty clinic deployments where validated, research‑grade 24‑hour recordings and integration with clinical systems matter most. Omron, A&D, and Microlife bridge home and ambulatory segments by offering validated cuff‑based ABPMs plus connectivity and companion software that support clinician review of 24‑hour profiles and home‑to‑clinic data sharing. Contec and other low‑cost manufacturers serve high‑volume primary care and emerging markets with basic ABPM capability and competitive pricing. Biobeat and other digital health challengers emphasize continuous, cuffless estimation, cloud analytics, and remote monitoring workflows that target outpatient, telehealth, and post‑acute care use cases. Each company’s competitive advantage is shaped by clinical validation status, regulatory approvals, device comfort for overnight wear, data management and connectivity, and distribution channels that determine adoption in ambulatory hypertension diagnosis and management.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.